Global Oral Dosage Forms Market Report 2021-2026: Current Market Dynamics and Outlook in the Oral Dose Contract Manufacturing Space

DUBLIN, October 22, 2021– (BUSINESS WIRE) – The “Oral Dosage Forms Market Outlook (4th Ed.)” Report has been added to offer.

This report provides an overview of the current market dynamics in the Oral Dose Contract Manufacturing space as well as an overview of what survey respondents – all decision makers in Oral Dose Outsourcing in Businesses. sponsor organizations – predict the market in 2026.

Oral dosage forms have a long history and dominate the market, making this class of pharmaceuticals a prime candidate for contract manufacturing, including to CMOs in emerging markets.

Key statistics include the volume of the oral dose project, the percentage contracted out and the average number of CMOs used to complete the job; an analysis of 17 different oral dosage forms that includes usage rates, the percentage of oral dosage products marketed for each form, the proportion of manufacturing that is outsourced by form, and a breakdown of outsourcing expenses by form as well than oral dosage forms which will be used more and more over the next five years and which could lose market share.

Additionally, contractors will share information on what works and what hasn’t when partnering with CMOs to manufacture oral pharmaceuticals.

What you will learn:

Drug developers:

  • Learn about the benefits and risks of offshoring oral dose manufacturing to emerging market CMOs

  • Improve your understanding of service provider selection and satisfaction factors that have contributed to positive sponsor-CMO peer relationships in the recent past, including textual responses on CMO preference

  • Find out what lifecycle extension strategies are being considered by peers as well as what peers think is driving the growth of the oral dosage forms market

Contract manufacturers:

  • Find out which oral dose technologies and capabilities are increasingly in demand by sponsoring organizations, as well as the volume of projects and propensity to outsource by company size to develop more targeted business development strategies

  • Understand which CMO attributes influence the selection of service provider for manufacturing simple and complex oral dose drugs to more effectively market your business capabilities and services

  • Learn competitive positioning from industry knowledge, usage, and preference rates from a set of 49 top marketing managers

Major topics:

  • Market dynamics

  • Perceptions and selection of service providers

  • Trends, forecasts and preferences

  • Geographic preferences

  • Study data

Main topics covered:

1. Introduction

2. Methodology

3. Respondents’ demographics

4. Main sections

5. Market dynamics

  • Primary section take-out

  • Oral Dosage Outsourcing Penetration

  • Outsourcing penetration by company size

  • Outsourcing penetration by company size

  • Current oral dose plan and CMO volume

  • Oral dose and CMO volume project in 5 years

  • The five main oral dosage forms

  • Oral Dosage Forms – Expected Growth Areas

  • Perceptions and selection of service providers

  • Primary section take-out

  • Knowledge of Service Providers – Top 10

  • Use by Service Providers – Top 10

  • Consideration and preference of the service provider –

  • Complex projects

  • Service provider selection attributes –

  • Complex projects

  • Consideration and preference of the service provider –

  • Simple projects

6. Service provider selection attributes

  • Simple projects

  • Reasons for the preference of the service provider

  • Satisfaction factors for service providers

  • Reasons why service providers lose deals

  • Number of preferred suppliers

7. Trends, forecasts and preferences

  • Primary section take-out

  • Life Cycle Management of Oral Dosage Forms

  • Lifecycle extension strategies

  • Growth drivers

  • Increasingly Demanded Oral Dose Technologies

  • Increasingly demanded CDMO capabilities

8. Geographic preferences

  • Primary section take-out

  • Use of emerging market suppliers

  • Oral dose manufacturing by region

  • Motivations behind the use or avoidance of emerging market suppliers

9. Study data

  • Oral Dosage Forms Market Dynamics

  • Oral dosage forms Current project volume and percentage contracted

  • Oral dosage forms Project volume and percentage contracted in five years

  • Characterization of Oral Dosage Form Manufacturing Projects

  • Number of contract manufacturers of oral dosage forms currently in use

  • Number of contracted oral dosage form manufacturers used in 5 years

  • Outsourced manufacturing services

  • Technologies used for oral drug products

  • Capacities required for outsourced oral dose manufacturing projects

  • Oral dosage forms used

  • Marketed Products Using Each Oral Dosage Form

  • Outsourced manufacturing for each oral dosage form

  • Outsourced expenditure by oral dosage form

  • Annual expenditure for outsourced oral dose manufacturing

  • Contract Manufacturing Satisfaction Factors for Oral Dosage Forms

  • Contract Manufacturing Satisfaction Factors for Oral Dosage Forms

  • Use of emerging market suppliers

  • Regional perceptions and preferences for the manufacture of oral dose drug products

  • Oral Dose Drug Product Manufacturing by Region

  • Reasons not to outsource manufacturing to emerging markets

  • Oral dosage forms Growth engines

  • Life Cycle Management of Oral Dosage Forms

  • Reasons why service providers lose deals

  • Using a List of Preferred Suppliers for Oral Dosage Forms

  • Number of preferred suppliers

  • Difficulty using a non-preferred supplier

  • Frequency of adding new preferred suppliers

  • Frequency of re-evaluation of preferred suppliers

  • Knowledge of the service provider

  • Use by the service provider

  • Service provider preference

  • Reasons for the preference of the service provider

  • Text responses for service provider preference

  • Perceptions and selection of service providers

  • Most important attributes of the service provider for complex projects

  • Service providers considered for complex projects

  • Service Provider Preference – Complex Projects

  • Most Important Service Provider Attributes for Simple Projects

  • Service providers considered for simple projects

  • Service Provider Preference – Simple Projects

  • Influence of the department on the selection of the CMO

10. Demographics

  • Company type

  • Decision-making responsibility

  • Profession

  • Outsourced activities

  • Outsourced activities

  • Involvement in outsourced activities

  • Involvement in the drug development process

  • Respondent’s location

For more information on this report, visit

View the source version on

Laura Wood, Senior Press Director
[email protected]
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

About Arla Lacy

Check Also

Multiconsult ASA (OSE: MULTI) – Mandatory Transaction Notification – Primary Insiders

20. May 2022 Grethe Bergly, CEO, has purchased 7,040 shares with a base volume of …